Latest papers

Alpha1-antitrypsin deficiency.

Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy

Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America.

Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis.

[Alpha-1-antitrypsin deficiency: diagnosis and therapy of the lung disease].

Lung volume reduction surgery for patients with alpha-1 antitrypsin deficiency emphysema.

Inherited metabolic disease of the liver.

Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood.

The impact of social contexts in testing for alpha-1 antitrypsin deficiency: the roles of physicians and others.

[Alpha-1 antitrypsin deficiency. The experience of Pulido Valente Hospital with augmentation therapy].

Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank.

Pneumothorax associated with alpha1-antitrypsin deficiency.

Heritability of lung function in severe alpha-1 antitrypsin deficiency.

Alpha-1-antitrypsin phenotypes in adult liver disease patients.

[Familial predisposition to chronic obstructive pulmonary disease].

[Two infants with bleeding caused by alpha-1-antitrypsin deficiency]

Long-term augmentation therapy with alpha-1 antitrypsin in an MZ-AAT severe persistent asthma.

On the evidence that augmentation therapy helps asthma: are storks really responsible for new babies?

Chronic sinusitis and alpha1-antitrypsin deficiency: potential role for protease in rhinosinusitis?

Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).